JAZZ icon

Jazz Pharmaceuticals
JAZZ

Overview Fund Activity

470 hedge funds and large institutions have $8.3B invested in Jazz Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 167 increasing their positions, 154 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
470
Holders Change
-14
Holders Change %
-2.89%
% of All Funds
7.52%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.08%
New
58
Increased
167
Reduced
154
Closed
63
Calls
$14.8M
Puts
$8.22M
Net Calls
+$6.55M
Net Calls Change
+$36.6M

Top Buyers

1
Swedbank
Swedbank
Sweden
$139M
2
Millennium Management
Millennium Management
New York
$175M
3
BG
Baupost Group
Massachusetts
$70M
4
DTC
Deep Track Capital
Connecticut
$176M
5
LSV Asset Management
LSV Asset Management
Illinois
$339M

Top Sellers

1
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$311M
2
Victory Capital Management
Victory Capital Management
Texas
$19.4M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
$99.9M
4
Citadel Advisors
Citadel Advisors
Florida
$39.9M
5
Fidelity Investments
Fidelity Investments
Massachusetts
$162M
Name Holding Trade Value Shares
Change 		Shares
Change %
CT
526
Cambridge Trust
Massachusetts
– -$4K -25 Closed
WTC
527
WhitTier Trust Company
Nevada
– -$1.91K -12 Closed
MSCM
528
McElhenny Sheffield Capital Management
Texas
– -$1.75K -11 Closed
AA
529
Addison Advisors
Vermont
– -$797 -5 Closed
RFG
530
RFP Financial Group
Georgia
– -$319 -2 Closed
CP
531
Castleview Partners
Texas
– -$159 -1 Closed
18 19 20 21
22